Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Neurology · Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids

Treatment Strategy and Relapse Management

At a Glance

CLIPPERS often improves quickly with high-dose steroids, but symptoms can return if treatment is reduced too quickly or stopped. Care usually requires a slow, supervised taper, possible steroid-sparing therapy, and monitoring for relapse and medication side effects.

The treatment of CLIPPERS is a long-distance journey rather than a quick fix. Because the condition is defined by its responsiveness to steroids, the first step is almost always to calm the intense inflammation in the brainstem [1]. However, the real challenge begins afterward: finding a way to keep the inflammation away while minimizing the side effects of long-term medication [2][3].

Important Warning: Never abruptly stop taking steroids or change your taper schedule without medical advice. Sudden withdrawal can cause a dangerous relapse of your neurological symptoms or a life-threatening condition called adrenal crisis.

The Acute Phase: Rapid Response

When you are first diagnosed, the goal is “induction”—calming the active inflammation. A commonly reported approach involves high-dose intravenous (IV) corticosteroids, such as methylprednisolone, often given as 1 gram per day for three to five days [3][4].

Many patients experience a dramatic improvement in their symptoms within days of starting IV steroids, and the small “pepper-like” spots on the MRI usually begin to fade or disappear within a month [5][3]. This rapid success is encouraging, but it is only the beginning of the management plan.

The Taper Challenge and Relapse

After the IV treatment, you will likely move to oral steroids (like prednisone) [3]. Your doctor will then attempt a taper, which is a gradual reduction of the dose over several months.

The primary difficulty in CLIPPERS is that it is often steroid-dependent. This means that if the dose is lowered too quickly or stopped entirely, the inflammation often returns [2][6].

  • Relapse Rates: Research suggests that without ongoing treatment, the risk of symptoms returning is high [2].
  • Dose Response Observations: While small observational studies noted that relapses were less common at doses above 20 to 30 milligrams of prednisone per day, there is no universally safe dose [2][7]. Never use these numbers to manage your own medication—always follow your doctor’s exact tapering instructions.
  • Relapse Signs: A relapse is not just a feeling of being tired; it is the return of objective neurological signs, such as double vision or new trouble walking, which often requires a clinical assessment before retreating with high-dose steroids [8][9]. Contact your specialist if you miss a dose, become ill, or notice returning symptoms.

Maintenance and Steroid-Sparing Agents

To avoid the long-term dangers of high-dose steroids, doctors often add an off-label steroid-sparing agent—a medication that suppresses the immune system through a different mechanism, allowing you to lower your steroid dose more safely [2].

  • Methotrexate: This is currently one of the most frequently used maintenance drugs in published case series [2][7]. It is taken once a week and helps keep the CD3+ T-cells in check [2].
  • Other Options: If methotrexate is not suitable, doctors may use other immunosuppressants like Azathioprine, Cyclophosphamide, or Rituximab [10][11]. These choices are highly individualized based on your age, overall health, and how your disease has behaved so far [11][9].
  • Pediatric Considerations: In children, CLIPPERS can sometimes be more “refractory” (difficult to treat), meaning it may require stronger combinations of these drugs to keep the disease stable [4][12].

Managing Long-Term Risks

Because you may need to be on some form of treatment for years, managing the side effects of medication is a critical part of your care.

  1. Bone Health: Prolonged steroid use can lead to osteoporosis (thinning of the bones) and fragility fractures [13]. Your doctor may recommend bone density scans (DEXA), Vitamin D, calcium supplements, or specialized bone-strengthening medications [13].
  2. Infection Risk: Since both steroids and maintenance drugs suppress your immune system, you are at a higher risk for infections, and steroids can mask early fever signs [12]. Staying up to date on vaccines and reporting fevers immediately is essential [12].
  3. Metabolic Changes: Steroids can also lead to weight gain, high blood pressure, and high blood sugar (steroid-induced diabetes), all of which require regular monitoring [14].
  4. Adrenal Suppression: Long-term steroids signal your body to stop making its own natural stress hormones, making a slow, medically supervised taper mandatory.
  5. Quality of Life Side Effects: Be aware of severe mood swings, insomnia, stomach irritation, and eye complications (such as cataracts or glaucoma) associated with prolonged steroid use.
  6. Routine Lab Work: If taking maintenance medications like methotrexate or azathioprine, you will require regular blood tests to safely monitor your liver function, kidney function, and blood cell counts.

The goal of treatment is to find the “lowest effective dose”—the smallest amount of medication that keeps your brain healthy and your symptoms at bay [2].

Common questions in this guide

What is the usual first treatment for CLIPPERS?
Doctors commonly begin with high-dose intravenous corticosteroids, such as methylprednisolone, to calm active inflammation. Treatment is often followed by oral steroids, such as prednisone, with a gradual taper; symptoms may improve within days and MRI findings may begin to fade within a month.
Why do CLIPPERS symptoms return when steroids are reduced?
CLIPPERS can be steroid-dependent, meaning inflammation may return when the dose is lowered too quickly or stopped. The taper must be planned and supervised by the treating clinician rather than adjusted by the patient.
What symptoms could signal a CLIPPERS relapse?
New or returning neurological problems, such as double vision or trouble walking, can signal a relapse. Contact your specialist promptly for a clinical assessment, because treatment decisions should not be based on symptoms alone or made without medical advice.
Which steroid-sparing medicines may be used for CLIPPERS?
Methotrexate is commonly used as a maintenance medicine to help reduce reliance on long-term steroids. Depending on the person’s health and disease course, clinicians may also consider azathioprine, cyclophosphamide, or rituximab; these treatments are individualized and may be used off-label.
How are long-term CLIPPERS treatment side effects monitored?
Follow-up may include checks of bone density, blood pressure, blood sugar, infection symptoms, mood, sleep, vision, and adrenal suppression. People taking medicines such as methotrexate or azathioprine also need regular blood tests to monitor blood cell counts, liver function, and kidney function.
What should I do if I miss a steroid dose or become ill?
Contact your specialist or care team promptly for specific instructions, especially if you miss a dose, develop an illness, or notice returning neurological symptoms. Do not stop, restart, or change the steroid dose or taper on your own.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is our target dose for my oral steroid taper, and how slowly will we reduce the medication?
  2. 2.What specific symptoms should prompt me to contact you immediately during the taper process?
  3. 3.If we use a steroid-sparing medication like methotrexate, what baseline tests (like liver, kidney, or hepatitis screening) do I need?
  4. 4.How frequently will I need blood tests to monitor for medication side effects?
  5. 5.What is our plan to protect my bone density and manage my risk for infections while my immune system is suppressed?
  6. 6.Are there specific vaccines I should receive before starting long-term maintenance therapy?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).

    Tobin WO, Guo Y, Krecke KN, et al.

    Brain : a journal of neurology 2017; (140(9)):2415-2425 doi:10.1093/brain/awx200.

    PMID: 29050399
  2. 2

    Therapeutic Approaches in CLIPPERS.

    Taieb G, Allou T, Labauge P

    Current treatment options in neurology 2017; (19(5)):17 doi:10.1007/s11940-017-0455-4.

    PMID: 28386850
  3. 3

    A case report of CLIPPERS syndrome with gait and cognitive impairment.

    Shrestha AM, Bashyal S, Kharbuja N, et al.

    BMC neurology 2025; (25(1)):470 doi:10.1186/s12883-025-04487-9.

    PMID: 41249905
  4. 4

    Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS): A pediatric case report with six year follow-up.

    Veerapandiyan A, Chaudhari A, Deo P, Ming X

    Multiple sclerosis and related disorders 2017; (17()):95-98 doi:10.1016/j.msard.2017.07.012.

    PMID: 29055484
  5. 5

    Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids Presenting With Predominantly Neuro-Ophthalmic Features.

    McDonald HM, Handzic A, Mandell DM, et al.

    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2025; (45(4)):460-465 doi:10.1097/WNO.0000000000002271.

    PMID: 39774846
  6. 6

    Increased Number of Perivascular CD20-Positive B Lymphocytes in the Neuropathology of CLIPPERS: Findings of 6 Patients from Mainland China.

    Yang B, Liu F, Li J, Wen Y

    European neurology 2021; (84(1)):22-30 doi:10.1159/000512406.

    PMID: 33498046
  7. 7

    CLIPPERS and its mimics: evaluation of new criteria for the diagnosis of CLIPPERS.

    Taieb G, Mulero P, Psimaras D, et al.

    Journal of neurology, neurosurgery, and psychiatry 2019; (90(9)):1027-1038 doi:10.1136/jnnp-2018-318957.

    PMID: 31072955
  8. 8

    Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS): contemporary advances and current controversies.

    Li EC, Lai QL, Cai MT, et al.

    Journal of neurology 2024; (271(4)):1747-1766 doi:10.1007/s00415-024-12189-4.

    PMID: 38286842
  9. 9

    Efficacy of Intravenous Immunoglobulins against Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids: A Case Report.

    Tsuchida T, Ura S, Yabe I

    Case reports in neurology 2023; (15(1)):48-53 doi:10.1159/000529121.

    PMID: 36938308
  10. 10

    CLIPPERS syndrome responsive to Leflunomide: A case report.

    Didier PJ, Adrián ML, Paola SA, et al.

    Multiple sclerosis and related disorders 2018; (25()):265-267 doi:10.1016/j.msard.2018.07.048.

    PMID: 30149302
  11. 11

    CLIPPERS Responsive to Cladribine as a Durable Steroid-Sparing Agent.

    Thebault S, Bergman H, Atkins HL, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2023; (10(1)) doi:10.1212/NXI.0000000000200060.

    PMID: 36396449
  12. 12

    Is chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) in children the same condition as in adults?

    Sa M, Green L, Abdel-Mannan O, et al.

    Developmental medicine and child neurology 2019; (61(4)):490-496 doi:10.1111/dmcn.13997.

    PMID: 30146710
  13. 13

    Monoclonal Gammopathy of Neurological Significance in a Patient With Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS Syndrome): A Case Report of a Rare Entity.

    Prieto-Torres AE, Esparza-Albornoz AS, Ovalle-Roa NA, et al.

    Cureus 2024; (16(8)):e67386 doi:10.7759/cureus.67386.

    PMID: 39310528
  14. 14

    Switch from previous major depression comorbid with CLIPPERS to mania-like episode following glucocorticosteroid therapy: a case report.

    Liu X, Wu Y

    General psychiatry 2018; (31(1)):e000007 doi:10.1136/gpsych-2018-000007.

    PMID: 30582117

This page is for informational purposes only and does not constitute medical advice about CLIPPERS. Never change or stop steroids without your neurologist’s guidance; your care team must tailor the taper and monitoring plan to you.

Get notified when new evidence is published on CLIPPERS.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.